ANDA 77190, held by Gland Pharma Ltd. Milrinone Lactate.
As of Nov 16, 2026, ANDA 77190 (Milrinone Lactate), held by Gland Pharma Ltd, was first approved by FDA on Oct 31, 2006, with 0 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Oct 31, 2006 | Original application | Approved | None posted |
| Product | Active ingredient | Marketing |
|---|---|---|
| Milrinone LactateEQ 1MG BASE/ML ยท injectable;injection | Milrinone Lactate | Discontinued |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters